Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now IOB - Delayed Quote • EUR Carl Zeiss Meditec AG (0DHC.IL) Follow Compare 48.61 -4.04 (-7.67%) At close: April 4 at 6:57:25 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0DHC.IL 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 0DHC.IL View More All News Press Releases SEC Filings ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach Carl Zeiss Meditec AG (ETR:AFX) Stock Goes Ex-Dividend In Just Three Days Carl Zeiss Meditec's (ETR:AFX) Dividend Will Be Reduced To €0.60 ZEISS Introduces VISULAS Combi in Canada; a Revolutionary Therapeutic Laser Workstation for Enhanced Eye Care European Market's Hidden Gems: ASML Holding And 2 Other Value Stocks When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)? ZEISS VISUMAX 800 with SMILE pro software receives approval in China Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Smaller Dividend Than Last Year Carl Zeiss Meditec AG (CZMWF) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Market ... The past three years for Carl Zeiss Meditec (ETR:AFX) investors has not been profitable ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow